Provizigen LLC

New York, NY

UEI
KT8KEDVPJJZ8
CAGE
9GB58
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Limited Liability Company
Entity structure
Other
SAM.gov registration date
Physical address
111 4th Ave #2m, New York, NY 10003, USA
Website
provizigen.com
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Sttr phase i: injectable biotherapeutic for treatment of post-traumatic osteoarthritis 2335299 National Science Foundation $295,000
Engineered biotherapeutic agent for treatment of post-traumatic osteoarthritis R41AR083738 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $954,961

Quick answers

Is Provizigen LLC registered in SAM.gov?

Yes. Provizigen LLC's SAM.gov registration is active through November 22, 2026.

What is Provizigen LLC's most recent federal award?

Provizigen LLC's most recent federal grant award is Sttr phase i: injectable biotherapeutic for treatment of post-traumatic osteoarthritis (2335299), from National Science Foundation, on November 1, 2023.

On GovTribe

See Provizigen LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login